Jul 16, 2026 / Data Book July 2026 Data Book: Health Care Spending and the Medicare Program Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality
Jul 16, 2026 / Data Book July 2026 Data Book Section 10: Prescription drugs Research Areas: Drugs, Devices, and Tests, Medicare Spending and Financing
Jun 30, 2026 Preferred networks and pharmacy access in Part D Research Areas: Drugs, Devices, and Tests
Jun 30, 2026 Examining the accuracy of drug prices displayed on Medicare Plan Finder Research Areas: Drugs, Devices, and Tests, Medicare Spending and Financing
Jun 30, 2026 Examining drivers of recent changes in Part D bids after the implementation of the Inflation Reduction Act Research Areas: Drugs, Devices, and Tests
Jun 15, 2026 / Reports June 2026 Report to the Congress: Medicare and the Health Care Delivery System Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Jun 15, 2026 / Chapters Executive summary (June 2026 report) Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Apr 13, 2026 / Transcripts April 2026 public meeting transcript Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Post-Acute Care, Private Plans, Quality, Regional Issues
Apr 10, 2026 / Presentations Preferred networks and pharmacy access in Part D Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Regional Issues
Apr 10, 2026 / Presentations Analysis of regional benchmarks and benchmark-plan availability in the Part D PDP market Research Areas: Drugs, Devices, and Tests, Regional Issues